生命科学资讯

Pfizer CEO lays blame for US vaccine woes on RFK Jr.'s 'anti-science' stance: WSJ

FDA outlines draft policy on MRD, complete response for accelerated approvals in multiple myeloma

J&J praises new FDA guidance to speed development of multiple myeloma drugs

Appointments and advancements for Jan. 21, 2026

Financings for Jan. 21, 2026

In the clinic for Jan. 21, 2026

Other news to note for Jan. 21, 2026

Regulatory actions for Jan. 21, 2026

Johnson & Johnson brushes off MFN impact, sees strong growth for 2026

Corvus shares nearly triple on positive data for eczema pill

Tanabe pill delays blood disorder; enGene adds up to $100M from loans

IntraBio says rare disease drug passes Phase 3, will seek FDA approval

J&J eyes $100B in sales amid gains for cancer, immune drugs

IO mulls more layoffs months after halving head count in wake of cancer vaccine setback

Touching base: Beam CEO on gene editing biotech's 'big push' for in vivo delivery

Cancer imaging company buys Lisata for phase 2-stage solid tumor drug

Novo Nordisk offloads diabetes assets to Aspect amid cell therapy retreat

Polymer Upcycling via Reactive Extrusion: FTIR Microscopy Unlocks Blend Compatibilization Insights - AZoM

#JPM26: Regeneron, Lilly, Summit on rivals crowding into same targets

Exclusive: Claim Health raises $4.4M to help home care providers get paid